Brian Levy
Vorstandsvorsitzender bei InflammX Therapeutics, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Richard Rubino | M | 66 |
InflammX Therapeutics, Inc.
 InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | 10 Jahre |
| Evan S. Melrose | M | 54 |
Spindletop Capital Management LLC
 Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | 16 Jahre |
| Rajiv Sarman Shukla | M | 49 |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA.
InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | 5 Jahre |
| David Alan Pool | M | - |
InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | - |
| Colin Richard Green | M | 80 |
InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | - |
| Robert Latella | M | 81 |
University of Rochester Medical Center
 University of Rochester Medical Center Other Consumer ServicesConsumer Services University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY. | - |
| Susan Holliday | F | 68 |
University of Rochester Medical Center
University of Rochester Medical Center Other Consumer ServicesConsumer Services University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY. | - |
| Jason Werner | M | 46 |
InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | - |
| Kelly Huang | M | 55 |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | 10 Jahre |
| Pat Basu | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Charles Fraser | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Craig R. Skenes | M | - | 10 Jahre | |
| Diana Kurty | F | 70 |
University of Rochester Medical Center
University of Rochester Medical Center Other Consumer ServicesConsumer Services University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY. | 3 Jahre |
| Kaylen Silverberg | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Phil Rosenfeld | M | - |
InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | - |
| Steven Goldman | M | 66 |
University of Rochester Medical Center
University of Rochester Medical Center Other Consumer ServicesConsumer Services University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY. | 21 Jahre |
| David Boyer | M | - |
InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | - |
| Robert C. McDonald | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Paul J. Tirjan | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Carl Miller | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Casey Runnels | F | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| George Vates | M | - |
University of Rochester Medical Center
University of Rochester Medical Center Other Consumer ServicesConsumer Services University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY. | - |
| Ralph Manchester | M | - |
University of Rochester Medical Center
University of Rochester Medical Center Other Consumer ServicesConsumer Services University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY. | - |
| Doug Ulman | M | 46 |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Shannon M. Rothschild | F | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Craig Cordola | M | 52 |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Steve Whitlock | M | 62 |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | 13 Jahre |
| Chen Ming Hu | M | 76 |
University of California, Berkeley
| 48 Jahre |
| Martin Birmingham | M | 57 |
University of Rochester Medical Center
University of Rochester Medical Center Other Consumer ServicesConsumer Services University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY. | - |
| James Blair | M | 84 |
InflammX Therapeutics, Inc.
InflammX Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy. | - |
| Steven Basta | M | 59 |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Marvin J. Garrett | M | 73 | 10 Jahre | |
| Paul A. Bartlett | M | 76 |
University of California, Berkeley
| 51 Jahre |
| David Nash | M | 68 |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Barton L. Sachs | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Richard A. Kaplan | M | 78 |
University of Rochester Medical Center
University of Rochester Medical Center Other Consumer ServicesConsumer Services University of Rochester Medical Center operates a medical center which offers healthcare, education and research services. It offers funding in biochemistry, microbiology and immunology, neurology, obstetrics and gynecology, oral biology and musculoskeletal research services. The firm’s departments include AIDS Center, Audiology and Aab Cardiovascular Research Institute. The company was founded by Abraham Flexner and Benjamin Rush Rhees in 1921 and is headquartered in Rochester, NY. | - |
| Fred Dinger | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Tom Rodgers | M | 53 |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Gordon B. Mills | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Rod J. Rohrich | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Stephen J. Spann | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Todd Fruchterman | M | 54 |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Eric George Flamholtz | M | 81 |
University of California, Berkeley
| 51 Jahre |
| George McLendon | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
| Erik Lundh | M | - |
Spindletop Capital Management LLC
Spindletop Capital Management LLC Investment ManagersFinance Spindletop Capital Management LLC (Spindletop Capital) is a private equity/venture capital firm founded in 2011. The firm is headquartered in Austin, Texas. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| William M. Carpenter | M | - |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 6 Jahre |
| Benjamin McGraw | M | 75 | 8 Jahre | |
| Thomas J. van Haarlem | M | - | 8 Jahre | |
| Thomas M. Riedhammer | M | 76 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 7 Jahre |
| Masao Yoshida | M | - | - | |
| Michael Heffernan | M | 59 | 4 Jahre | |
| William H. Waltrip | M | 86 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 17 Jahre |
| Carl E. Sassano | M | 74 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 27 Jahre |
| Paul Wotton | M | 63 | 2 Jahre | |
| Edward Myles | M | 52 | 3 Jahre | |
| Carl Perez | M | - |
University of California, Berkeley
| 8 Jahre |
| Jackie W. Hoffmann | F | - |
University of California, Berkeley
| 6 Jahre |
| Rob Pomeroy | M | 73 |
University of California, Berkeley
| 5 Jahre |
| Gerald Ostrov | M | 73 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 2 Jahre |
| Hal R. Varian | M | - |
University of California, Berkeley
| 4 Jahre |
| David Soane | M | - |
University of California, Berkeley
| 3 Jahre |
| Kathleen M. Hagerty | M | - |
University of California, Berkeley
| 6 Jahre |
| Thomas J. Burr | M | - |
University of California, Berkeley
| 3 Jahre |
| Julie McHugh | F | 59 | 7 Jahre | |
| Zohar Loshitzer | M | 67 | 5 Jahre | |
| Linda Friedman | F | - | - | |
| Michael D. Gowen | M | 75 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | - |
| Susan A. Roberts | F | 61 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | - |
| Steven J. McCormick | M | - |
University of California, Berkeley
| 7 Jahre |
| Chiu Yum Ling | M | 74 |
University of California, Berkeley
| 5 Jahre |
| Michael T. Williams | M | 56 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 18 Jahre |
| Michael McCleerey | M | - | 8 Jahre | |
| Michael du Toit | M | 71 | 7 Jahre | |
| Yue Nong Chow | M | 74 |
University of California, Berkeley
| 6 Jahre |
| Joel Caldwell | M | 69 |
University of California, Berkeley
| 6 Jahre |
| Shieng-Chang Tseng | M | 74 |
University of California, Berkeley
| 4 Jahre |
| Elizabeth J. Cabraser | F | - |
University of California, Berkeley
| 7 Jahre |
| Janet L. Conway | M | 74 | 9 Jahre | |
| Vicente J. Anido | M | 71 | 8 Jahre | |
| James Hildebrand Roberts | M | 67 |
University of California, Berkeley
| 5 Jahre |
| James Lightman | M | 65 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 3 Jahre |
| Stephen McCluski | M | 72 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 19 Jahre |
| Dennis J. Henner | M | 72 | 4 Jahre | |
| Murray Goldberg | M | 79 | 7 Jahre | |
| Mary E. Doyle | F | 72 |
University of California, Berkeley
| 4 Jahre |
| David Roger Ditzel | M | 67 |
University of California, Berkeley
| 5 Jahre |
| Alan C. Shapiro | M | 78 | 11 Jahre | |
| Robert Langer | M | 74 | 5 Jahre | |
| Richard Croarkin | M | 69 | 7 Jahre | |
| Robert Gayton | M | 84 |
University of California, Berkeley
| 9 Jahre |
| Robert S. Townsend | M | 68 |
University of California, Berkeley
| 4 Jahre |
| Craig Tooman | M | 58 | 4 Jahre | |
| Thomas A. Mitro | M | 66 | 9 Jahre | |
| Jerry R. Solomon | M | 73 |
University of California, Berkeley
| 5 Jahre |
| David Mack | M | 62 | 8 Jahre | |
| Gerald D. Cagle | M | 79 | 9 Jahre | |
| Gregory Perry | M | 63 | 5 Jahre | |
| Rick Anderson | M | 63 | 3 Jahre | |
| Robert Schrader | M | 52 |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | 10 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 99 | 100,00% |
| Kanada | 0 | -.--% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Brian Levy
- Persönliches Netzwerk